Phase II Axitinib (AG-013736) in Elderly Glioblastoma Multiforme (GBM) Patients
Clinical trial NCT01508117 · TERMINATED
Trial details
- NCT number
- NCT01508117
- Sponsor
- University of Cincinnati
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2012-10-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.